首页> 外国专利> Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin

Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin

机译:鼻内注射胰岛素治疗和预防患者社交障碍的方法

摘要

Methods for delivering an effective amount of insulin to the central nervous system to treat Social Communication Disorder while minimizing systemic exposure to the administered insulin. The present invention provides these advantages by administering at least an effective amount of insulin and/or pharmaceutical composition(s) thereof, to the upper third of the nasal cavity, thereby bypassing the blood-brain barrier and delivering an effective amount of insulin and/or pharmaceutical compound(s) thereof directly to the CNS. Further methods comprise administering an at least an effective amount of therapeutic agents to the amniotic fluid surrounding a fetus with a treatable neurologic agent or a preventable neurologic condition. For example, administering the at least effective amount of insulin to the amniotic fluid of a fetus with a mother diagnosed with gestational diabetes may prevent the fetus from developing Social Communication Disorder or autism.
机译:将有效量的胰岛素输送到中枢神经系统以治疗社会交往障碍,同时最大程度地减少对所施用胰岛素的全身暴露的方法。本发明通过向鼻腔的上三分之一施用至少有效量的胰岛素和/或其药物组合物来提供这些优点,从而绕过血脑屏障并递送有效量的胰岛素和//或其药物化合物直接连接到CNS。进一步的方法包括将至少有效量的治疗剂与可治疗的神经药或可预防的神经病施用于胎儿周围的羊水。例如,与被诊断患有妊娠糖尿病的母亲一起向胎儿的羊水施用至少有效量的胰岛素可能会阻止胎儿发展为社会交往障碍或自闭症。

著录项

  • 公开/公告号US10279012B2

    专利类型

  • 公开/公告日2019-05-07

    原文格式PDF

  • 申请/专利权人 HEALTHPARTNERS RESEARCH & EDUCATION;

    申请/专利号US201414202932

  • 发明设计人 WILLIAM H. FREY II;

    申请日2014-03-10

  • 分类号A61K38/28;A61K9/00;A61K38/18;A61K38/51;A61K45/06;

  • 国家 US

  • 入库时间 2022-08-21 12:12:38

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号